HK1048980A1 - Crystalline form of (s)-2 ethoxy-3-4-(2-4-methanesulfonyloxyphenyl ethoxy) phenylÜ propanoic acid (s)-2-3-Ä4 - Google Patents

Crystalline form of (s)-2 ethoxy-3-4-(2-4-methanesulfonyloxyphenyl ethoxy) phenylÜ propanoic acid (s)-2-3-Ä4

Info

Publication number
HK1048980A1
HK1048980A1 HK03101132A HK03101132A HK1048980A1 HK 1048980 A1 HK1048980 A1 HK 1048980A1 HK 03101132 A HK03101132 A HK 03101132A HK 03101132 A HK03101132 A HK 03101132A HK 1048980 A1 HK1048980 A1 HK 1048980A1
Authority
HK
Hong Kong
Prior art keywords
ethoxy
phenylü
methanesulfonyloxyphenyl
crystalline form
propanoic acid
Prior art date
Application number
HK03101132A
Other languages
English (en)
Inventor
Maria Boije
Karol Horvath
Tord Inghardt
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9904416A external-priority patent/SE9904416D0/xx
Priority claimed from SE0001187A external-priority patent/SE0001187D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of HK1048980A1 publication Critical patent/HK1048980A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63Esters of sulfonic acids
    • C07C309/64Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66Methanesulfonates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK03101132A 1999-12-03 2003-02-17 Crystalline form of (s)-2 ethoxy-3-4-(2-4-methanesulfonyloxyphenyl ethoxy) phenylÜ propanoic acid (s)-2-3-Ä4 HK1048980A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9904416A SE9904416D0 (sv) 1999-12-03 1999-12-03 Crystalline form
SE0001187A SE0001187D0 (sv) 2000-04-03 2000-04-03 Crystalline form
PCT/SE2000/002384 WO2001040171A1 (en) 1999-12-03 2000-11-29 Crystalline form of (s)-2 ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl} ethoxy) phenyl] propanoic acid

Publications (1)

Publication Number Publication Date
HK1048980A1 true HK1048980A1 (en) 2003-04-25

Family

ID=26655058

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03101132A HK1048980A1 (en) 1999-12-03 2003-02-17 Crystalline form of (s)-2 ethoxy-3-4-(2-4-methanesulfonyloxyphenyl ethoxy) phenylÜ propanoic acid (s)-2-3-Ä4

Country Status (30)

Country Link
US (1) US6531622B1 (xx)
EP (1) EP1237855B1 (xx)
JP (1) JP2003515582A (xx)
KR (1) KR20030029040A (xx)
CN (1) CN1198799C (xx)
AR (1) AR029412A1 (xx)
AT (1) ATE261431T1 (xx)
AU (1) AU773777B2 (xx)
BR (1) BR0016131A (xx)
CA (1) CA2392038A1 (xx)
CO (1) CO5271735A1 (xx)
CZ (1) CZ20021902A3 (xx)
DE (1) DE60008921T2 (xx)
DK (1) DK1237855T3 (xx)
EE (1) EE200200278A (xx)
ES (1) ES2215769T3 (xx)
HK (1) HK1048980A1 (xx)
HU (1) HUP0203444A3 (xx)
IL (1) IL149577A0 (xx)
IS (1) IS6400A (xx)
MX (1) MXPA02005327A (xx)
MY (1) MY135954A (xx)
NO (1) NO20022598L (xx)
NZ (1) NZ518925A (xx)
PL (1) PL357118A1 (xx)
PT (1) PT1237855E (xx)
RU (1) RU2268880C2 (xx)
SK (1) SK7652002A3 (xx)
TR (1) TR200401333T4 (xx)
WO (1) WO2001040171A1 (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6130214A (en) 1997-10-27 2000-10-10 Dr. Reddy's Research Foundation Benzothiazin and benzoxazin derivatives; their preparation and uses
HUP0101110A3 (en) 1997-10-27 2002-06-28 Reddys Lab Ltd Dr Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them
US6440961B1 (en) 1997-10-27 2002-08-27 Dr. Reddy's Research Foundation Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
US6369067B1 (en) 1997-10-27 2002-04-09 Dr. Reddy's Research Foundation Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
PL193086B1 (pl) 1997-10-27 2007-01-31 Reddys Lab Ltd Dr Nowe związki tricykliczne i związki pośrednie, sposób ich wytwarzania, zawierające je kompozycje farmaceutyczne oraz ich zastosowanie
UA60386C2 (uk) 1998-10-29 2003-10-15 Reddys Laboratories Ltd Спосіб одержання похідних 3-[4-[2-(феноксазин-10-іл)метокси]феніл]пропіонової кислоти (варіанти) та проміжні сполуки для їх отримання
US6531596B1 (en) 1998-10-29 2003-03-11 Dr. Reddy's Laboratories Ltd. Process for the preparation of new antidiabetic agents
US7084177B2 (en) * 1999-12-03 2006-08-01 Astrazeneca Ab Comminuted form of(S)-2-ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl}ethoxy)phenyl] propanoic acid
US6897199B2 (en) 2001-02-05 2005-05-24 Dr. Reddy's Laboratories Ltd. Pharmaceutically acceptable salts of phenoxazine and phenothiazine compounds
DE10308352A1 (de) 2003-02-27 2004-09-09 Aventis Pharma Deutschland Gmbh Arylcycloalkylderivate mit verzweigten Seitenketten, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
DE10308353A1 (de) 2003-02-27 2004-12-02 Aventis Pharma Deutschland Gmbh Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US7148246B2 (en) 2003-02-27 2006-12-12 Sanofi-Aventis Deutschland Gmbh Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals
DE10308355A1 (de) 2003-02-27 2004-12-23 Aventis Pharma Deutschland Gmbh Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
DE10308351A1 (de) 2003-02-27 2004-11-25 Aventis Pharma Deutschland Gmbh 1,3-substituierte Cycloalkylderivate mit sauren, meist heterocyclischen Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US7829552B2 (en) 2003-11-19 2010-11-09 Metabasis Therapeutics, Inc. Phosphorus-containing thyromimetics
DE602004004631D1 (de) 2004-04-01 2007-03-22 Sanofi Aventis Deutschland Oxadiazolone, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Pharmazeutika
DE102004035034A1 (de) * 2004-07-20 2006-02-16 Degussa Ag Racematspaltung von p-Hydroxyphenyl-2-alkoxy-propionsäuren
DE102005026762A1 (de) 2005-06-09 2006-12-21 Sanofi-Aventis Deutschland Gmbh Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
US20120046364A1 (en) 2009-02-10 2012-02-23 Metabasis Therapeutics, Inc. Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9801992D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl-2-hydroxypropionic acid derivative I
MA26634A1 (fr) 1998-06-04 2004-12-20 Astra Ab Nouveaux derives de l'acide 3-aryl propionique et analogues
SE9801990D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl propionic acid derivatives and analogs

Also Published As

Publication number Publication date
ES2215769T3 (es) 2004-10-16
EE200200278A (et) 2003-06-16
CZ20021902A3 (cs) 2002-11-13
MXPA02005327A (es) 2002-12-06
MY135954A (en) 2008-07-31
EP1237855A1 (en) 2002-09-11
CN1198799C (zh) 2005-04-27
NZ518925A (en) 2004-06-25
RU2002113450A (ru) 2004-01-10
PL357118A1 (en) 2004-07-12
IS6400A (is) 2002-05-28
WO2001040171A1 (en) 2001-06-07
BR0016131A (pt) 2002-08-20
AU2035001A (en) 2001-06-12
HUP0203444A3 (en) 2003-05-28
ATE261431T1 (de) 2004-03-15
KR20030029040A (ko) 2003-04-11
NO20022598D0 (no) 2002-05-31
HUP0203444A2 (hu) 2003-02-28
CA2392038A1 (en) 2001-06-07
SK7652002A3 (en) 2002-11-06
US6531622B1 (en) 2003-03-11
EP1237855B1 (en) 2004-03-10
IL149577A0 (en) 2002-11-10
DE60008921T2 (de) 2005-01-20
JP2003515582A (ja) 2003-05-07
AU773777B2 (en) 2004-06-03
CN1409701A (zh) 2003-04-09
CO5271735A1 (es) 2003-04-30
AR029412A1 (es) 2003-06-25
RU2268880C2 (ru) 2006-01-27
DE60008921D1 (en) 2004-04-15
PT1237855E (pt) 2004-06-30
DK1237855T3 (da) 2004-06-14
NO20022598L (no) 2002-05-31
TR200401333T4 (tr) 2004-08-23

Similar Documents

Publication Publication Date Title
HK1048980A1 (en) Crystalline form of (s)-2 ethoxy-3-4-(2-4-methanesulfonyloxyphenyl ethoxy) phenylÜ propanoic acid (s)-2-3-Ä4
HUP0001560A3 (en) Stable crystal salts of 5-methyl-tetrahydrofolic acid
HUP0300592A3 (en) Process for the preparation of 2-halobenzoic acid derivatives
HK1049324A1 (en) Comminuted form of (s)-2-ethoxy-3-4-(2-4-methanesulfonyloxyphenyl ethoxy) phenyl) propanoic acid
AU1283200A (en) Propanoic acid derivatives as integrin inhibitors
PL342817A1 (en) Novel derivatives of dihydroxyhexanic acid
AU2001288092A1 (en) Method of crystallization
AU2001286163A1 (en) An improved process for the preparation of 3-aryl-2-hydroxy propanoic acid derivatives
HUP0103788A3 (en) Processes for the preparation of 5-hydroxy-3-oxopentanoic acid derivatives
HUP0202728A3 (en) Process for preparation of phenylacetic acid derivatives
AU2233001A (en) Preparation method of methacrylic acid
AU6484599A (en) An improved process for the preparation of 7-azaindolyl-3-carboxylic acid
AU7958000A (en) Process for the preparation of oxyiminoalkanoic acid derivatives
SI1237855T1 (en) Crystalline form of (s)-2 ethoxy-3- 4-(2- 4-methanesulfonyloxyphenyl ethoxy) phenyl) propanoic acid
PL338742A1 (en) Method of obtaining derivatives of dioxypenicillanic acid
PL338405A1 (en) Method of obtaining 2-quinoxalincarboxylic acid
AU2001273189A1 (en) Process for the preparation of derivatives of 4-amino-3-hydroxypyrrole-2-carboxylic acid
AU3354200A (en) Production of 2-carboxyalkyl (phenyl) phosphinic acid
AU2001237790A1 (en) Method for the preparation of (s)-2-acetylthio-3-phenylpropionic acid
SI1237854T1 (en) Comminuted form of (s)-2-ethoxy -3- 4-(2- 4-methanesulfonyloxyphenyl ethoxy) phenyl) propanoic acid
EP1275642A4 (en) A METHOD FOR CRYSTALLIZING 2-ACETHYLTHIO-3-PHENYL PROPANIC ACID
PL332532A1 (en) Method of obatining 4-amino-5-hexenic acid
PL331905A1 (en) Method of obtaining p-chlorophenylamide of 3-methyl-5-benzoylamino isothiazolo-4-carboxylic acid
GB9924766D0 (en) New use of acetyl salicilic acid
AU2002341106A1 (en) Method of synthesising chicoric acid

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20091129